Consumables

Bio-Rad Laboratories anti-pembrolizumab and anti-nivolumab antibodies

29 May, 2018 | Supplied by: Bio-Rad Laboratories Pty Ltd

Bio-Rad Laboratories has launched a range of anti-idiotypic antibodies targeting the immune checkpoint inhibitor drugs pembrolizumab (Keytruda) and nivolumab (Opdivo). Anti-pembrolizumab and anti-nivolumab antibodies are designed for use in bioanalytical assays to monitor the drug levels in cancer patients.


Bio-Rad Laboratories anti-vedolizumab antibodies

17 May, 2018 | Supplied by: Bio-Rad Laboratories Pty Ltd

Bio-Rad's anti-vedolizumab antibodies include four recombinant monoclonal anti-idiotypic antibodies that are highly specific for the humanised IgG1 kappa antibody drug vedolizumab, and are suitable for development of bioanalytical and patient monitoring assays.


Bio-Rad StarBright Blue 520 Fluorescent Secondary Antibodies

16 May, 2018 | Supplied by: Bio-Rad Laboratories Pty Ltd

Bio-Rad Laboratories has announced the StarBright Blue 520 Fluorescent Secondary Antibodies — fluorescent dye-labelled secondary antibodies for use in multiplex western blotting.


BOC made-to-order gas mixtures

01 May, 2018 | Supplied by: BOC Limited

BOC can deliver locally made, complex gas mixtures containing up to 70 components.


Antibacterial specialist Stayzon set to expand internationally

16 April, 2018

Fresche Bioscience has signed an agreement to support manufacture of Stayzon's range of antimicrobial coatings and ancillary treatments.


Artificial enzymes use light to kill bacteria

05 April, 2018

Made from tiny nanorods, the newly developed 'NanoZymes' use visible light to create highly reactive oxygen species that rapidly break down and kill bacteria.


Enzo Life Sciences Nupherin transfection reagent

20 March, 2018 | Supplied by: Sapphire Bioscience

Nupherin, from Enzo Life Sciences, is a peptide-based transfection reagent that combines a non-classical nuclear localisation sequence (M9) with a nucleotide binding domain, thereby helping to transport DNA into the transfected cell's nucleus.


AdipoGen Life Sciences anti-α-Tubulin, recombinant antibodies

19 March, 2018 | Supplied by: Sapphire Bioscience

AdipoGen Life Sciences' anti-α-Tubulin monoclonal antibodies (recombinant) are composed of human variable regions (VH and VL) (λ-chain) of immunoglobulin fused to the human lgG2 Fc domain.


Chemists challenged to help curb mercury poisoning

08 February, 2018 | Supplied by: Flinders University

Mercury poisoning through artisanal and small-scale gold mining is increasing — but Dr Justin Chalker believes that chemists can provide cheap and effective solutions to curb the damage.


Advanced Analytical Technology High Sensitivity Fragment Analysis Kits for cfDNA quality control

19 December, 2017 | Supplied by: Millennium Science Pty Ltd

Advanced Analytical Technology's line of High Sensitivity Fragment Analysis Kits for its Fragment Analyzer Automated Capillary Electrophoresis System can measure the size and concentration of the three common cfDNA fragments using only 2 mL of sample.


EpiGentek CRISPR/Cas9 SaCas9 Monoclonal Antibody [6H4]

11 December, 2017 | Supplied by: Sapphire Bioscience

EpiGentek has released a monoclonal antibody that is specific to Staphylococcus aureus Cas9 (SaCas9) and enables easy and specific monitoring of gene editing processes.


CHROMagar COL-APSE growth medium for colistin-resistant bacteria

03 November, 2017 | Supplied by: Dutec Diagnostics Pty Ltd

CHROMagar COL-APSE is a sensitive and specific medium for the selective growth of colistin-resistant bacterial pathogens.


Improved culture medium for IVF now available in Australia

31 October, 2017

Fertility group Genea has announced an updated version of its culture medium Gems, which is claimed to result in more high-grade embryos per IVF cycle than traditional products.


Abcam RabMAb recombinant rabbit monoclonal antibodies

12 October, 2017 | Supplied by: Abcam Australia Pty Ltd

Abcam has combined the advantages of its RabMAb rabbit monoclonals with recombinant technology to deliver high-performance antibodies.


ProSci Risk-Free Antibody Sets

11 October, 2017 | Supplied by: Sapphire Bioscience

ProSci's Risk-Free Antibody Sets consist of several monoclonal antibodies (20 µg each) against a single target, allowing selection of the best clone for specific applications. Antibodies were developed using recombinant proteins expressed in mammalian cells to best recognise the native proteins.


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd